| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 427 | 1.876 | 247 | 0 | 0 | 6.635 | 42.455 | 198.054 | 264.187 | 360.541 |
| Total Income - EUR | 652 | 7.777 | 247 | 215 | 224 | 70.599 | 68.902 | 208.696 | 268.881 | 390.855 |
| Total Expenses - EUR | 96 | 7.363 | 123 | 0 | 0 | 64.411 | 66.103 | 147.928 | 201.507 | 288.842 |
| Gross Profit/Loss - EUR | 556 | 414 | 123 | 215 | 224 | 6.188 | 2.799 | 60.768 | 67.375 | 102.013 |
| Net Profit/Loss - EUR | 537 | 258 | 121 | 213 | 222 | 6.122 | 1.936 | 58.723 | 64.784 | 90.287 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 8 |
Check the financial reports for the company - Dalumaxin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.759 | 3.939 | 11.044 | 94.159 | 285.090 | 391.164 | 414.301 | 419.365 | 401.500 | 411.363 |
| Current Assets | 556 | 1.998 | 225.474 | 173.578 | 140.310 | 119.139 | 50.453 | 54.024 | 51.760 | 71.346 |
| Inventories | 12 | 62 | 32 | 538 | 528 | 16.038 | 7.080 | 14.762 | 31.672 | 21.425 |
| Receivables | 169 | 459 | 200.347 | 163.235 | 138.967 | 99.121 | 33.194 | 29.301 | 5.892 | 21.048 |
| Cash | 375 | 1.476 | 25.096 | 9.805 | 816 | 3.981 | 10.179 | 9.961 | 14.196 | 28.873 |
| Shareholders Funds | 1.311 | 1.600 | 1.694 | 1.876 | 2.062 | 8.144 | -9.348 | 49.346 | 113.980 | 203.630 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 2.947 | 8.276 | 45.178 | 87.904 | 258.366 | 314.485 | 294.758 | 254.596 | 187.255 | 138.436 |
| Income in Advance | 0 | 0 | 198.726 | 195.079 | 191.301 | 187.674 | 179.344 | 169.447 | 152.025 | 140.643 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
5520
|
|||||||||
Comments - Dalumaxin S.r.l.